Balancing the risk of stroke and bleeding in atrial fibrillation patients with a history of falls - Latt NKZ, Calvert P, Lip GYH.
INTRODUCTION: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, and can lead to serious consequences such as ischemic stroke and systemic thromboembolism. The risk of thromboembolism can be reduced by anticoagulation, however many p... (Source: SafetyLit)
Source: SafetyLit - October 23, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Tenecteplase Non-inferior to Alteplase in Stroke: ATTEST-2 Tenecteplase Non-inferior to Alteplase in Stroke: ATTEST-2
This result, along with its ease of use, adds to the growing evidence that tenecteplase should be a first-line thrombolytic agent, trial investigators say.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 21, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
Nigeria: World Thrombosis Day - Walk, Stretch Regularly to Move Against Thrombosis, Nigerians Told
[Vanguard] ...As global campaign promotes blood clot prevention (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 17, 2023 Category: African Health Tags: Health and Medicine Nigeria West Africa Source Type: news
Improving Outcomes in Cancer-Associated Thrombosis Improving Outcomes in Cancer-Associated Thrombosis
Explore cancer-associated thrombosis from its clinical implications to treatment advancements. This symposium offers insights on venous thromboembolism in cancer, risk assessment, and integrated patient care.Medscape Medical Affairs (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2023 Category: Consumer Health News Tags: None Virtual Symposium Source Type: news
Strategy to Prevent Blood Clots, Deaths in Lung/GI Cancer Strategy to Prevent Blood Clots, Deaths in Lung/GI Cancer
An approach that involves stratifying patients by thrombosis risk reduced the incidence of thromboembolism and death among high-risk individuals with lung and GI cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 27, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
'I'm a venous surgeon - here's the best and easiest way to cut your risk of blood clots'
A leading venous surgeon has recommended a simple movement that could be very effective at reducing your risk of deep vein thrombosis. (Source: Daily Express - Health)
Source: Daily Express - Health - September 27, 2023 Category: Consumer Health News Source Type: news
Another Win for Biomarker-Driven Thromboprophylaxis for Patients With Cancer
(MedPage Today) -- Biomarker-directed thromboprophylaxis in the outpatient setting significantly reduced the frequency of thromboembolism in high-risk patients with gastrointestinal (GI) or lung cancers, a randomized trial showed.
Patients at... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 21, 2023 Category: Cardiology Source Type: news
Link Explored for NSAID Use, Hormonal Contraception, VTE Risk
MONDAY, Sept. 11, 2023 -- In women of reproductive age, nonsteroidal anti-inflammatory drug (NSAID) use is associated with venous thromboembolism, with significantly more additional events with concomitant use of high-/medium- versus low-/no-risk... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 11, 2023 Category: Pharmaceuticals Source Type: news
Venous thromboembolism warning over contraceptive pills with NSAIDs
Women taking non-steroidal anti-inflammatory drugs (NSAIDs) while on contraceptive pills are more likely to suffer potentially fatal venous thromboembolic events (VTE), according to new research. Concerns have been raised that using common painkillers – including ibuprofen – alongside hormonal contraception, can lead to an increased risk of VTE, according to the Danish study published by the BMJ. Those taking... Read moreThe post Venous thromboembolism warning over contraceptive pills with NSAIDs appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - September 7, 2023 Category: Nursing Authors: Megan Ford Tags: Clinical Latest news Women's health Source Type: news
Apixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism
TUESDAY, Sept. 5, 2023 -- Apixaban has a lower bleeding risk than warfarin or rivaroxaban during initial treatment for patients with venous thromboembolism (VTE), according to a study published online Aug. 28 in the Journal of Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 5, 2023 Category: Pharmaceuticals Source Type: news
What Are the Complications of Sickle Cell Trait?
Discussion
Sickle cell disease (SCD) is a group of inherited blood disorders where there are abnormal hemoglobin molecules and the red blood cells take on a characteristic sickled shape instead of a rounded shape. Sickled hemoglobin provides an evolutionary advantage of giving the individual increased protection against severe and cerebral malaria. The sickled shape doesn’t move through the vascular system as well and therefore is more likely to aggregate in small vessels causing an increased risk of vaso-occlusive disease, acute chest syndrome, splenic sequestration, and priapism. There is also an increased risk of ...
Source: PediatricEducation.org - September 4, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Cancer Therapy's Lower-Limb Blood Clots Better Treated With Long Anticoagulation
(MedPage Today) -- AMSTERDAM -- A prolonged course of edoxaban (Savaysa) was more effective for isolated distal deep vein thrombosis in cancer patients, the ONCO DVT randomized trial showed.
By 12 months, symptomatic recurrent venous thromboembolism... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 29, 2023 Category: Cardiology Source Type: news
Is intimate partner abuse undestimated as a precipitating factor for venous thromboembolism in women? - Gris JC, Nikolaeva MG, Khizroeva J, Bitsadze V, Makatsariya A, Ripart S, Perez-Martin A.
Major and minor trauma increase the risk of venous thromboembolism but violence against young women is not reported as a precipitating factor for thrombosis. Here, we report 20 cases of first VTE events in women of childbearing age after evidence of intima... (Source: SafetyLit)
Source: SafetyLit - August 26, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
Prolonged Direct Oral Anticoagulants Beneficial for Preventing Recurrent VTE
MONDAY, Aug. 21, 2023 -- For patients with venous thromboembolism (VTE) continuing warfarin or direct oral anticoagulants (DOACs) beyond six months, the risk for recurrent VTE is lower with DOACs, according to a study published online Aug. 15 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 21, 2023 Category: Pharmaceuticals Source Type: news
Thromboprophylaxis in pediatric patients with earthquake-related crush syndrome: a single centre experience - Karahan F, Ünal S, Tezol, Sürmeli Döven S, Durak F, Alakaya M, Mısırlıoğlu M, Yeşil E, Kıllı, Kurt H, Altunköprü G.
In this study, we aimed to share our experience about anticoagulant... (Source: SafetyLit)
Source: SafetyLit - August 21, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
